MapLight Therapeutics, Inc. (MPLT)
7.44
+0.16
(+2.20%)
USD |
NASDAQ |
Nov 10, 16:00
7.46
+0.02
(+0.27%)
After-Hours: 20:00
MapLight Therapeutics Cash from Operations (Annual) : -138.14M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -138.14M |
| December 31, 2024 | -78.82M |
| Date | Value |
|---|---|
| December 31, 2023 | -52.01M |
| December 31, 2022 | -26.58M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Cullinan Therapeutics, Inc. | -175.75M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |
| Sarepta Therapeutics, Inc. | -222.54M |